Aberrant ERK signaling promotes cancer invasiveness, and GSCs rely on ERK signaling transduction to regulate the interaction between N-cadherin and ITGA6, thereby modulating GSC invasion in vitro (Velpula et al., 2012). The gene discussed is ITGA6; the disease is cancer.